Navigation Links
Clinical trial seeks to determine whether platelet-rich plasma can ease the pain of osteoarthritis
Date:3/22/2011

For years, doctors have used platelet-rich plasma, or PRP, to promote healing after surgery. Now, Rush University Medical Center is studying whether PRP can help relieve knee pain in patients with mild to moderate osteoarthritis.

PRP contains growth factors that promote cell proliferation and is prepared from the patient's own blood tissue. It has received popular attention recently because of its use in treating sports injuries in professional athletes, but the jury is still out on whether it is effective.

"There have been few controlled clinical trials, and results are inconsistent, but data so far suggests that it could be a promising treatment for healing in a variety of tissues," said Dr. Brian Cole, orthopedic surgeon and head of the cartilage restoration center at Rush. "The therapy will not be a cure for osteoarthritis, but it could help put off the day when a patient will need to get a knee implant." Cole is professor of orthopedic surgery at Rush University and head team physician for the Chicago Bulls.

At present, the standard of care is either corticosteroid injections, which may provide relief for about three months, or synthetic lubricants containing hyaluronic acid, which can last for up to a year.

In the double-blind, randomized, controlled study, 100 patients will receive either hyaluronic acid or PRP. The PRP is prepared from 10 millimeters of the patient's own blood. The blood is spun in a centrifuge to separate the platelets from the red and white blood cells. The platelets are then injected into the knee joint using ultrasound imaging to guide placement.

Patients will receive three injections over three weeks and will be monitored for two years. In periodic clinical exams, the physician will assess pain and knee function. In addition, a teaspoon-size sample will be taken of the synovial fluid around the knee joint to test for molecular changes that may indicate a shift in the balance of anabolic factors that increase the buildup of tissue and catabolic factors that break it down. An imbalance in these factors has been implicated in the deterioration of cartilage that leads to osteoarthritis.


'/>"/>

Contact: Sharon Butler
Sharon_Butler@rush.edu
312-942-7816
Rush University Medical Center
Source:Eurekalert

Related medicine news :

1. Jefferson clinical trial: Can a cholesterol drug prevent colon cancer?
2. Clinical trial for dry mouth funded by international oral care award
3. Revitalizing Cancer Clinical Trials -- March 21 symposium
4. Novel clinical trial aims to reduce recurrence of aggressive breast cancer
5. Clinical observation leads to lung cancer discovery
6. Study reveals security weaknesses in file-sharing methods used in clinical trials
7. UT Southwestern launches clinical trial for treatment of breast cancer using CyberKnife
8. Elsevier/MEDai enhances real-time clinical surveillance system for hospitals
9. Few physicians refer patients to cancer clinical trials
10. Older adults often excluded from clinical trials
11. New clinical trial to determine ovarian cancer risks in African-American women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2017)... ... ... Springfield, Vermont-based law firm of Brady/Callahan has released a new Personal Injury ... Experienced Personal Injury Attorney, " the article offers insight for people who have questions, ... if someone is injured due to another person's negligence, they may want ...
(Date:5/19/2017)... ... May 19, 2017 , ... ... class of Beckman Young Investigators: , Victor Acosta, Ph.D. - University of New ... Dan Fu, Ph.D. - University of Washington, Erik Grumstrup, Ph.D. - Montana Stata ...
(Date:5/19/2017)... ... ... ML Billing, 2016 Billing Company of the Year , a family-owned company ... is pleased to announce their 30th anniversary. Not only has ML Billing thrived in ... of full-service medical billing. This has allowed ML Billing to excel for more than ...
(Date:5/19/2017)... (PRWEB) , ... May 18, 2017 , ... Somnoware, a ... sleep labs and physicians to independently dispense CPAP devices and supplies, such as machines, ... sleep labs can dispense the devices. Device registration for daily usage data is automated, ...
(Date:5/18/2017)... Franklin, TN (PRWEB) , ... May 18, 2017 ... ... treatment and behavioral health services, today announced the acquisition of English Mountain Recovery. ... addiction treatment center will be Summit’s first facility in the state and brings ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... 10, 2017 CSSi, the global leader in ... research industry, is proud to announce the launch of ... website features both enriched content and a customized layout ... the company,s already well-established position as the top global ... "After many months of hard work, we are delighted ...
(Date:5/9/2017)... 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral ... Intellectual Property Office has granted Oramed a patent ... Exenatide". The patent covers Oramed,s invention of an ... is an incretin hormone that stimulates the secretion ...
(Date:5/8/2017)... 8, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO)., has ... ("WRB"), a health care service center company based in ... specializes in relationship management programs for leading pharmaceutical manufacturers ... WRB will join Envoy Health Management, ... for manufacturers, biotech firms, and other service companies. Together, ...
Breaking Medicine Technology: